Upcoming Webinars

European Market Access for Medical Devices: What Does It Take?

Written by ADMINUSER | Nov 16, 2026, 3:29:01 PM
From MDR compliance to CE marking: understanding the regulatory challenges facing manufacturers and subcontractors

 

24 November 2026 |2:00–3:00 PM (Morocco Time) | Online

Held in French

 

Entering the European medical device market is a significant opportunity for manufacturers and subcontractors. But between developing a medical device and placing it on the EU market lies a complex regulatory journey.

What does it really take to bring a medical device to the European market, and where should companies focus their efforts to avoid unnecessary delays?

With Regulation (EU) 2017/745 (MDR) establishing the regulatory framework for medical devices in the European Union, companies must navigate requirements that extend across device classification, conformity assessment, quality management, technical documentation and clinical evaluation.

For manufacturers established outside the EU, the challenge also involves understanding the specific obligations associated with accessing the European market.

A clear regulatory strategy is therefore essential, not only to demonstrate compliance but also to support a more predictable and efficient route to market.

 

The CE Marking Journey: More Than a Regulatory Milestone

CE marking represents a critical step towards placing a medical device on the European market. However, reaching that milestone requires a structured approach from the earliest stages of regulatory planning.

One of the first considerations is understanding how the nature and classification of a medical device influence the applicable compliance requirements.

From there, companies must identify the relevant stages of the conformity assessment process and determine which regulatory activities and documentation are necessary.

The challenge is not simply knowing what the MDR requires. It is understanding how those requirements translate into concrete actions throughout the market access process.

This is particularly relevant for organisations seeking to accelerate market entry while maintaining the necessary level of regulatory compliance.

 

Documentation, Quality and Clinical Evidence: Connecting the Requirements

A successful regulatory strategy depends on more than completing individual compliance activities.

Quality management systems, technical documentation and clinical evaluation are essential elements of the MDR framework, and understanding their respective requirements is fundamental to preparing for European market access.

For manufacturers and subcontractors, this means recognising how regulatory expectations relate to their activities and responsibilities.

Addressing these requirements through a coordinated approach can help organisations identify potential challenges earlier and prepare more effectively for the stages leading to CE marking.

 

Beyond EU Borders: Additional Considerations for International Manufacturers

For manufacturers established outside the European Union, accessing the EU market introduces another layer of regulatory considerations.

Understanding the obligations applicable to non-EU manufacturers is an important part of preparing a compliant market entry strategy.

Companies must be able to identify the requirements relevant to their situation, understand the steps involved in demonstrating conformity and anticipate the challenges that may arise during the process.

Whether an organisation is preparing its first entry into the European market or reviewing its existing approach, regulatory clarity can make a meaningful difference in planning and execution.

 

From Regulatory Complexity to a Clearer Route to Market

What are the most common challenges companies encounter when preparing for MDR compliance? Which steps require particular attention? And how can organisations identify the support needed to navigate the regulatory process more effectively?

These questions will be at the centre of ProductLife Group's upcoming webinar:

“Medical Devices: Access to the European Market for Manufacturers and Subcontractors”

During this free session, PLG experts will explore the essential regulatory requirements and share practical considerations to help manufacturers and subcontractors better understand the European market access process.

 

Key Topics Covered

  • The European regulatory framework: an overview of Regulation (EU) 2017/745 (MDR) and its implications for medical devices.
  • Device classification and compliance: understanding the requirements applicable to different types and classes of medical devices.
  • The CE marking process: identifying the main stages from initial regulatory assessment to market placement.
  • Quality and regulatory documentation: examining requirements for quality management systems, technical documentation and clinical evaluation.
  • Non-EU manufacturers: understanding specific obligations when accessing the European market.
  • Compliance challenges and support: identifying common difficulties and possible approaches to addressing them.

By the end of the session, participants will have a clearer understanding of the European regulatory landscape and the actions needed to support compliant and timely market access.


Speakers: Thierry Sirdey, Vincent Lere, Karine Bonenfant and Abderrahim Bouabidi

Held in French

 

Register for free

 

Discover the regulatory fundamentals, compliance considerations and practical approaches that can help your organisation prepare for European medical device market access.